Երկիր: Ավստրալիա
Լեզու: անգլերեն
Աղբյուրը: Department of Health (Therapeutic Goods Administration)
bicalutamide, Quantity: 50 mg
Dr Reddys Laboratories Australia Pty Ltd
Bicalutamide
Tablet, film coated
Excipient Ingredients: microcrystalline cellulose; hypromellose; lactose monohydrate; crospovidone; sodium lauryl sulfate; magnesium stearate; titanium dioxide; macrogol 400
Oral
28 tablets, 30 Tablets
(S4) Prescription Only Medicine
Treatment of advanced prostate cancer in combination with LHRH agonist therapy. Prevention of disease flare associated with the use of LHRH agonists.
Visual Identification: White, round, biconvex, immediate release, film coated tablets debossed with R on one side and "573" on the other side.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 2 Years; Container Temperature: Store below 30 degrees Celsius
Licence status A
2011-06-01
BICALUTAMIDE-DRLA _Bicalutamide _ CONSUMER MEDICINE INFORMATION _ _ WHAT IS IN THIS LEAFLET This leaflet answers some of the common questions people ask about Bicalutamide-DRLA. It does not contain all the information that is known about Bicalutamide-DRLA. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor will have weighed the risks of you taking Bicalutamide-DRLA against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT BICALUTAMIDE-DRLA IS FOR Bicalutamide-DRLA is used in combination with other medicines to treat advanced prostate cancer. Bicalutamide-DRLA is an anti-androgen medicine. Androgens such as testosterone are natural male sex hormones. In some types of prostate cancer, androgens may help the cancer cells to grow. Bicalutamide-DRLA interferes with some of the actions of these hormones. Bicalutamide-DRLA should only be taken by men. FOLLOW ALL DIRECTIONS GIVEN TO YOU BY YOUR DOCTOR. They may differ from the information in this leaflet. Your doctor may prescribe this medicine for another use. Ask your doctor if you want more information. Bicalutamide-DRLA is not addictive. BEFORE YOU USE BICALUTAMIDE-DRLA _WHEN YOU MUST NOT USE IT _ DO NOT TAKE BICALUTAMIDE-DRLA IF YOU ARE A WOMAN. Women are not normally treated with Bicalutamide-DRLA. DO NOT GIVE BICALUTAMIDE-DRLA TO CHILDREN. There is no experience of its use in children. DO NOT TAKE BICALUTAMIDE-DRLA IF YOU ARE ALLERGIC TO BICALUTAMIDE OR ANY OF THE OTHER INGREDIENTS IN BICALUTAMIDE-DRLA. DO NOT TAKE BICALUTAMIDE-DRLA IF YOU ARE TAKING CISAPRIDE OR THE ANTIHISTAMINES, TERFENADINE AND ASTEMIZOLE. DO NOT TAKE BICALUTAMIDE-DRLA AFTER THE USE BY (EXPIRY) DATE PRINTED ON THE PACK. It may have no effect at all or an unexpected effect if you take it after the expiry date. DO NOT TAKE BICALUTAMIDE-DRLA IF THE PACKAGING IS TORN OR SHOWS SIG Կարդացեք ամբողջական փաստաթուղթը